Axol Bioscience raised €2.4M in a funding round in Jan 2026. The company is based in Cambridge, UK. Investors in the round: BroadOak Capital Partners, Roslin Foundation. Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
